Impact of Pharmaceutical Interviews Regarding the Management of Adverse Effects Related to the Antibiotic Therapy Used to Treat Osteoarticular Infections During Return Home
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 90
- 试验地点
- 1
- 主要终点
- Adverse effects self-management measurement
研究概览
简要总结
The primary objective is to evaluate the impact of Pharmaceutical Interviews in the patient self-management of non-severe side effects caused by antibiotics prescribed for the treatment of osteoarticular infections when the patient returns home.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Supportive Care
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patient > or =18 years;
- •Informed consent signed;
- •French-speaking and reading;
- •Affiliated to a social insurance;
- •Benefiting from medical and surgical care for an osteoarticular infection;
- •Treated with an oral antibiotic therapy on discharge from hospital.
- •Indication of the antibiotic therapy osteoarticular infection;
- •Return home immediately after discharge.
排除标准
- •Refusal to participate
- •Protected adult patient, under guardianship or curatorship.
- •Minor patient
- •Patient benefiting from an AME.
- •Pregnant or breastfeeding woman.
- •Non-French speaking patient.
- •Patient unable to understand the course of the study.
- •Patient with a documented history of cognitive or psychiatric disorders.
- •Patient treated with oral antibiotic therapy for an indication other than osteoarticular infection.
- •Patient treated with parenteral antibiotic therapy.
- •Discharge: Institution (EHPAD), rehabilitation or other health establishment.
- •Patient systematically using one of the symptomatic treatments proposed in the discharge prescription before hospitalization.
研究组 & 干预措施
Patients with pharmaceutical interview
Pharmaceutical interview with pharmacist: to be informed treatment taken and related SAE informations at the end of hospitalization.
干预措施: pharmaceutical interview (Other)
Patients without pharmaceutical interview
Control group without interview
结局指标
主要结局
Adverse effects self-management measurement
时间窗: at day 14
Phone call to evaluate the self-management of adverse effects. Self-management evaluation (optimal choice/non-optimal choice) performs thanks to the use of a standardized decision-tree. Proportion of patients with an optimal or non-optimal self-management.
Adverse effects self-management measurement
时间窗: at day 7
Phone call to evaluate the self-management of adverse effects. Self-management evaluation (optimal choice/non-optimal choice) performs thanks to the use of a standardized decision-tree. Proportion of patients with an optimal or non-optimal self-management.
次要结局
- Patient knowledge assessment(at day 7)